Barrett's esophagus: Management of high-grade dysplasia and cancer

Journal of Surgical Research

Volumn 117, Issue 1, 2004, Pages 44-51

  Ruol, Alberto ^a   Zaninotto, Giovanni ^a   Costantini, Mario ^a   Battaglia, Giorgio ^a   Cagol, Matteo ^a   Alfieri, Rita ^a   Epifani, Magdalena ^a   Ancona, Ermanno ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Adenocarcinoma; Barrett's esophagus; High grade dysplasia (HGD)

Indexed keywords

AMINOLEVULINIC ACID; PHOTOFRIN; PHOTOSENSITIZING AGENT;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; DRUG SAFETY; DRUG SELECTIVITY; DYSPLASIA; ELECTROCOAGULATION; ENDOSCOPIC BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; ESOPHAGUS STRICTURE; HUMAN; HYPERTHERMIC THERAPY; LASER COAGULATION; MEDICAL ASSESSMENT; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PLEURA EFFUSION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SURGICAL TECHNIQUE; TACHYCARDIA; THORAX PAIN; TUMOR BIOPSY;

EID: 1542298299     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2003.10.021     Document Type: Article

References (69)

1. Pera M., Cameron A.J., Trastek V.F., Carpenter H.A., Zinsmeister A.R. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 104:1993;510.
2. Kalish R.J., Clancy P.E., Orringer M.B., Appelman H.D. Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's mucosa and in the gastric cardia. Gastroenterology. 86:1984;461.
3. Devesa S.S., Blot W.J., Fraumeni J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 83:1998;2049.
4. Ellis F.H.J., Heatley G.J., Krasna M.J., Williamson W.A., Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia A comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J. Thorac. Cardiovasc. Surg. 113:1997;836.
5. Eloubeidi M.A., Mason A.C., Desmond R.A., ElSerag H.B. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States A glimmer hope? Am. J. Gastroenterol. 98:2003;1627.
6. Spechler S.J. The natural history of dysplasia and cancer in esophagitis and Barrett esophagus. J. Clin. Gastroenterol. 36:(Suppl. 1):2003;S2.
7. Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am. J. Gastroenterol. 97:2002;1888.
8. Greence R.T., Hill-Harmon M.B., Murray T., Thun M. Cancer statistics, 2001. CA Cancer J. Clin. 51:2001;15.
9. Reid B.J., Levine D.S., Longton G., Blount P.L., Rabinovitch P.S. Predictors of progression to cancer in Barrett's esophagus Baseline histology and flow cytometry identify low- and high-risk patient subsets. Am. J. Gastroenterol. 95:2000;1669.
10. Avidan B., Sonnenberg A., Schnell T.G., Chejfec G., Metz A., Sontag S.J. Hiatal hernia, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am. J. Gastroenterol. 97:2002;1930.
11. Buttar N.S., Wang K.K., Sebo T.J., Riehle D.M., Krishnadath K.K., Lutzke L.S., Anderson M.A., Petterson T.M., Burgart L.J. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology. 120:2001;1630.
12. Ferguson M.K., Durkin A. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J. Gastrointest. Surg. 6:2002;29.
13. Corley D.A., Levin T.R., Habel L.A., Weiss N.S., Buffler P.A. Surveillance and survival in Barrett's adenocarcinomas A population-based study. Gastroenterology. 122:2002;633.
14. Dulai G.S., Guha S., Kahn K.L., Gornbein J., Weinstein W.M. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma A systematic review. Gastroenterology. 122:2002;26.
15. Sharma P., Weston A.P., Topalovski M., Cherian R., Bhattacharyya A., Sampliner R.E. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gut. 52:2003;24.
16. van Lieshout E.M., Jansen J.B., Peters W.H. Biomarkers in Barrett's esophagus. Int. J. Oncol. 13:1998;855.
17. Jenkins G.J.S., Doak S.H., Parry J.M., D'Souza F.R., Griffiths A.P., Baxter J.N. Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma. Br. J. Surg. 89:2002;824.
18. Wijnhoven B.P., Tilanus H.W., Dinjens W.N. Molecular biology of Barrett's adenocarcinoma. Ann. Surg. 233:2001;322.
19. Krishnadath K.K., Reid B.J., Wang K.K. Biomarkers in Barrett esophagus. Mayo Clin. Proc. 76:2001;438.
20. Reid B.J., Blount P.L., Rabinovich P.S. Biomarkers in Barrett's esophagus. Gastrointest. Endosc. Clin. N. Am. 13:2003;369.
21. Levine D.S. Management of dysplasia in the columnar-lined esophagus. Gastroenterol. Clin. N. Am. 26:1997;613.
22. Begg C.B., Cramer L.D., Hoskins W.J., Brennan M.F. Impact of hospital volume on operative mortality for major cancer surgery. J. Am. Med. Assoc. 280:1998;1747.
23. Patti M.G., Corvera C.U., Glasgow R.E., Way L.W. A hospital's annual rate of esophagectomy influences the operative mortality rate. J. Gastrointest. Surg. 2:1998;186.
24. Birkmeyer J.D., Siewers A.E., Finlayson E.V., Stukel T.A., Lucas F.L., Batista I., Welch H.G., Wennberg D.E. Hospital volume and surgical mortality in the United States. New Engl. J. Med. 346:2002;1128.
25. Falk G.W., Rice T.W., Goldblum J.R., Richter J.E. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest. Endosc. 49:1999;170.
26. Sampliner R.E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am. J. Gastroenterol. 93:1998;1028.
27. Levine D.S., Haggitt R.C., Blount P.L., Rabinovitch P.S., Rusch V.W., Reid B.J. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology. 105:1993;40.
28. Reid B.J., Blount P.L., Feng Z., Levine D.S. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am. J. Gastroenterol. 95:2000;3089.
29. Weston A.P., Banerjee S.K., Sharma P., Tran T.M., Richards R., Cherian R. p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus Immunohistochemical marker predictive of progression. Am. J. Gastroenterol. 96:2001;1355.
30. Edwards M., Gable D., Lentsch A. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann. Surg. 223:1996;585.
31. Cameron A.J. Management of Barrett's esophagus. Mayo Clin. Proc. 73:1998;457.
32. Lim K.N., Waring P.J., Saidi R. Therapeutic options in patients with Barrett's esophagus. Dig. Dis. 17:1999;145.
33. Selvasekar C.R., Birbeck N., McMillan T., Wainwright M., Walker S.J. Photodynamic therapy and the alimentary tract. Aliment. Pharmacol. Ther. 15:2001;899.
34. Peters J.H., Clark G.W., Ireland A.P., Chandrasoma P., Smyrk T.C., DeMeester T.R. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J. Thorac. Cardiovasc. Surg. 108:1994;813.
35. Ferguson M.K., Naunheim K.S. Resection for Barrett's mucosa with high-grade dysplasia Implications for prophylactic photodynamic therapy. J. Thorac. Cardiovasc. Surg. 114:1997;824.
36. Pellegrini C.A., Pohl D. High-grade dysplasia in Barrett's esophagus surveillance or operation? J. Gastrointest. Surg. 4:2000;131.
37. Heitmiller R.F., Redmond M., Hamilton S.R. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann. Surg. 224:1996;66.
38. van den Boogert J., van Hillegersberg R., Siersema P.D., de Bruin R.W., Tilanus H.W. Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia a review. Am. J. Gastroenterol. 94:1999;1153.
39. Collard J.M. Exclusive radical surgery for esophageal adenocarcinoma. Cancer. 91:2001;1098.
40. Falk G. Unresolved issues in Barrett's esophagus in the new millennium. Dig. Dis. 18:2000;27.
41. Schnell T.G., Sontag S.J., Chejfec G., Aranha G., Metz A., O'Connell S., Seidel U.J., Sonnenberg A. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 120:2001;1607.
42. Levine D.S., Haggitt C.R., Irvine S., Reid B.J. Natural history of high-grade dysplasia in Barrett's esophagus. Gastroenterology. 110:1996;A550.
43. Weston A.P., Sharma P., Topalovski M., Richards R., Cherian R., Dixon A. Long-term follow-up of Barrett's high-grade dysplasia. Am. J. Gastroenterol. 95:2000;1888.
44. Sontag S., Schnell T., Chejfec G., Kurucar C., O'Connell S., Levine G., Karpf J., Adelman K., Brand L., Seidel J. Barrett's high grade dysplasia Surveillance endoscopy once a year is sufficient in most patients. Gastroenterology. 116:1999;A304.
45. van Sandick J.W., van Lanschot J.J., ten Kate F.J., Offerhaus G.J., Fockens P., Tytgat G.N., Obertop H. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction Implications for therapeutic decision making. Cancer. 88:2000;2429.
46. Headrick J.R., Nichols F.C., Miller D.L., Allen M.S., Trasteck V.F., Deschamps C., Schleck C.D., Thompson A.M., Pairolero P.C. High-grade esophageal dysplasia Long-term survival and quality of life after esophagectomy. Ann. Thorac. Surg. 73:2002;1697.
47. Tseng E.E., Wu T.T., Yeo C.J., Heitmiller R.F. Barrett's esophagus with high grade dysplasia Surgical results and long-term outcome - An update. J. Gastrointest. Surg. 7:2003;164.
48. Spechler S.J. Clinical practice. Barrett's esophagus. New Engl. J. Med. 346:2002;836.
49. van Laethem J.L., Peny M.O., Salmon I., Cremer M., Deviere J. Intramucosal adenocarcinoma arising under squamous re-epithelisation of Barrett's oesophagus. Gut. 46:2000;574.
50. Krishnadath K.K., Wang K.K., Taniguchi K., Sebo T.J., Buttar N.S., Anderson M.A., Lutzke L.S., Liu W. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology. 119:2000;624.
51. Overholt B.F., Panjehpour M., Halberg D.L. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma Long term results. Gastrointest. Endosc. 58:2003;183.
52. Wolfsen H.C., Woodward T.A., Raimondo M. Photodynamic therapy for dysplastic Barrett's esophagus and early esophageal adenocarcinoma. Mayo Clin. Proc. 77:2002;1176.
53. Gossner L., Stolte M., Sroka R., Rick K., May A., Hahn E.G., Ell C. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology. 114:1998;448.
54. Weston A.P., Sharma P. Neodymium yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Am. J. Gastroenterol. 97:2002;2998.
55. Nijhawan P.K., Wang K.K. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest. Endosc. 52:2000;328.
56. May A., Gossner L., Pech O., Fritz A., Gunter E., Mayer G., Muller H., Seitz G., Vieth M., Stolte M., Ell C. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus Acute-phase and intermediate results of a new treatment approach. Eur. J. Gastroenterol. Hepatol. 14:2002;1085.
57. Ell C., May A., Gossner L., Pech O., Gunter E., Mayer G., Henrich R., Vieth M., Muller H., Seitz G., Stolte M. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology. 118:2000;670.
58. Buttar N.S., Wang K.K., Lutzke L.S., Krishnadath K.K., Anderson M.A. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest. Endosc. 54:2001;682.
59. Panjehpour M., Overholt B.F., Haydek J.M., Lee S.G. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Am. J. Gastroenterol. 95:2000;2177.
60. Kaklamanos I.G., Walker G.R., Ferry K., Franceschi D., Livingstone A.S. Neoadjuvant treatment for resectable cancer of the esophagus and gastroesophageal junction a meta-analysis of randomized clinical trials. Ann. Surg. Oncol. 10:2003;754.
61. van Sandick J.W., van Lanschot J.J., Kuiken B.W., Tytgat G.N., Offerhaus G.J., Obertop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut. 43:1998;216.
62. Paraf F., Fléjou J.F., Pignon J.P., Fékété F., Potet F. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. Am. J. Surg. Pathol. 19:1995;183.
63. Siewert J.R., Feith M., Werner M., Stein H.J. Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients. Ann. Surg. 232:2000;353.
64. Gregory P., Bhathal P.S., Abbott M., Thomas R.J.S., Mortsyn G. Clinical and pathologic similarity between adenocarcinoma of Barrett's esophagus and gastric cardia. Dis. Esophagus. 2:1989;191.
65. Husemann B. Cardia carcinoma considered as a distinct clinical entity. Br. J. Surg. 76:1989;136.
66. Tytgat G.N.J., Hameeteman W. The neoplastic potential of columnar-lined (Barrett's) esophagus. World J. Surg. 16:1992;308.
67. Zaninotto G., Parenti A.R., Ruol A., Costantini M., Merigliano S., Ancona E. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br. J. Surg. 87:2000;1102.
68. Ruol A., Merigliano S., Baldan N., Santi S., Bonavina L., Ancona E., Peracchia A. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophagogastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). Dis. Esophagus. 10:1997;190.
69. George S.J., Sharma P. Barrett's high-grade dysplasia Wait and watch? Am. J. Gastroenterol. 97:2002;2674.